Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges

Area of Science:

• Endocrinology
• Oncology
• Clinical Chemistry

Background:

• Differentiated thyroid cancer (DTC) incidence is rising globally.
• Standard treatment involves total thyroidectomy and radioiodine ablation.
• Thyroglobulin (Tg) is a key biomarker for DTC recurrence monitoring.

Purpose of the Study:

• Evaluate the impact of new, highly sensitive Tg assays in DTC follow-up.
• Assess the utility of these assays in detecting minimal residual disease.
• Highlight the importance of understanding assay limitations and interpretation criteria.

Main Methods:

• Review of current and emerging Tg assay technologies.
• Analysis of Tg detection capabilities with and without TSH stimulation.
• Discussion of clinical implementation challenges and interpretation guidelines.

Main Results:

• Highly sensitive Tg assays can detect minimal thyroid tissue without TSH stimulation.
• These assays offer improved precision at low concentrations.
• TSH stimulation may become unnecessary with advanced assay sensitivity.

Conclusions:

• New Tg assays enhance DTC follow-up by detecting minimal disease.
• Understanding technical challenges and interpretation is vital for clinicians and lab scientists.
• Clinical guidelines need to adapt to incorporate these advanced Tg assays.